Author: digi

Phase 3 Trials in Oncology: Tumor Response vs. Overall Survival as Endpoints

June 17, 2025

Phase 3 Trials in Oncology: Tumor Response vs. Overall Survival as Endpoints Understanding Tumor Response and Overall Survival in Oncology Phase 3 Trials Why Endpoint Selection Is Critical in Oncology Trials Phase 3 clinical trials in oncology are the definitive step before regulatory approval of anti-cancer therapies. The choice of primary endpoints can significantly impact…

Phase 3 (Confirmation and Monitoring)

Comparative Cost Analysis: Niche vs Full-Service CROs

June 17, 2025

digi

Comparative Cost Analysis: Niche vs Full-Service CROs Comparing Costs Between Niche and Full-Service CROs in Clinical Trials Cost plays a pivotal role in clinical outsourcing strategy. Whether a sponsor is launching a Phase I proof-of-concept study or managing a global Phase III trial, selecting the right Contract Research Organization (CRO) depends heavily on financial analysis….

Contract Research Organizations (CROs), Niche/Specialty CROs

Multinational Post-Marketing Surveillance Programs in Phase 4 Clinical Trials

June 17, 2025

digi

Multinational Post-Marketing Surveillance Programs in Phase 4 Clinical Trials Designing and Managing Global Post-Marketing Surveillance in Phase 4 Clinical Trials Introduction Once a drug is approved for commercial use, its real-world performance must be monitored continuously and comprehensively. When marketed across different countries, multinational post-marketing surveillance (PMS) programs become a critical component of Phase 4…

Phase 4 (Post-Marketing Surveillance)

Challenges in Gaining Informed Consent at Cluster Level – Clinical Trial Design and Protocol Development

June 17, 2025

digi

Challenges in Gaining Informed Consent at Cluster Level – Clinical Trial Design and Protocol Development “Difficulties in Obtaining Informed Consent at the Group Level” Introduction Gaining informed consent at the cluster level poses various challenges in clinical studies. This process, which is central to ethical research, often confronts issues related to cultural, linguistic, and educational…

Clinical Trial Design and Protocol Development, Cluster Randomized Trials

Global Harmonization of Phase 1 Requirements – US, EU, Japan, India

June 17, 2025

digi

Global Harmonization of Phase 1 Requirements – US, EU, Japan, India Aligning Phase 1 Clinical Trials Across Regulatory Regions Introduction As drug development becomes increasingly global, sponsors must navigate differing regulatory frameworks when planning Phase 1 trials across regions. While there is general alignment through ICH guidelines, specific requirements for study design, safety monitoring, documentation,…

Phase 1 (Safety and Dosage)

How to Develop a Patient Enrollment Plan for Clinical Trials

June 16, 2025

digi

Step-by-Step Guide to Developing a Patient Enrollment Plan for Clinical Trials Patient enrollment is often the most time-consuming and resource-intensive aspect of clinical trial execution. A well-structured enrollment plan can dramatically improve recruitment timelines, reduce screen failures, and ensure regulatory alignment. This tutorial offers a structured approach to designing and implementing a successful patient enrollment…

Clinical Research Operations, Patient Enrollment Strategies

Objectives of the Site Close-Out Visit (COV) in Clinical Trials

June 16, 2025

digi

Key Objectives of a Site Close-Out Visit (COV) in Clinical Trials As a clinical trial concludes at an investigative site, the sponsor or Contract Research Organization (CRO) schedules a Site Close-Out Visit (COV). This critical milestone ensures that all trial-related activities have been properly completed, documented, and archived, and that the site is compliant with…

Site Close-Out Visits, Site Management and Monitoring

Data Protection in Telemedicine for Clinical Trials

June 16, 2025

digi

Data Protection in Telemedicine for Clinical Trials How to Ensure Data Protection in Telemedicine for Clinical Trials With the rise of decentralized clinical trials (DCTs), telemedicine has become a central tool for patient engagement. While it offers unmatched convenience and scalability, it also introduces serious data protection challenges. Clinical trial data is highly sensitive, governed…

Decentralized Clinical Trials (DCTs), Telemedicine in Trials

eConsent Tools for Simplified Patient Onboarding in Clinical Trials

June 16, 2025

digi

eConsent Tools for Simplified Patient Onboarding in Clinical Trials Streamlining Patient Onboarding with eConsent Tools in Clinical Trials Patient onboarding is a critical first step in any clinical trial, and informed consent is at its core. Traditionally, this process has involved lengthy documents and in-person explanations, which often lead to confusion, delays, and high drop-off…

Patient Engagement Tools, Patient Recruitment and Retention

Timelines for Initial and Ongoing Ethics Reviews in Clinical Trials

June 16, 2025

digi

Timelines for Initial and Ongoing Ethics Reviews in Clinical Trials Understanding Timelines for Initial and Ongoing Ethics Committee Reviews in Clinical Trials Timely Ethics Committee (EC) or Institutional Review Board (IRB) approval is critical for launching and maintaining clinical trials. Navigating the various timelines for initial and continuing reviews ensures smoother study start-up, regulatory compliance,…

Ethics Committee Submissions, Informed Consent and Ethics Committees